Strikingly, comparison of these data to published TEAD ChIP-Seq from various YAPon cancers demonstrated distinct binding patterns and showed that TEADs (and presumably YAP/TAZ) are recruited to distinct enhancers in YAPon vs. YAPoff solid cancers [14]. The gene discussed is YAP1; the disease is cancer.